Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Continuing Full Induction Regimen Not Beneficial in Metastatic CRC

drugsDecember 23, 2019

Tag: CRC , metastatic colorectal cancer , cytotoxic chemotherapy

PharmaSources Customer Service